Gustavo Mahler
Vorstandsvorsitzender bei Cellistic
Profil
Gustavo Mahler currently works at Ncardia SA, as Chief Executive Officer & Director from 2023, Cellistic, as Chief Executive Officer & Director from 2023, Alpenglow Biosciences, Inc., as Director, Lucid Scientific, Inc., as Director, Curi Bio, Inc., as Board Member & Advisor, CellFE, Inc., as Board Member & Advisor, and Vernal Biosciences, Inc., as Board Member & Advisor.
Dr. Mahler also formerly worked at AGC Biologics A, as President & Chief Executive Officer from 2016 to 2019, Bayer AG, as Regional Manager, AGC Biologics, Inc., as President, Bayer HealthCare, as Vice President from 2003 to 2008, Absci Corp., as Board Member from 2018 to 2021, Dynamk Capital LLC, as Venture Partner from 2019 to 2022, and Life Science Washington, as Executive Board Member from 2018 to 2022.
Dr. Mahler received his Masters Business Admin degree in 2002 from Universidad Nacional de Educación a Distancia and undergraduate degree in 1992, doctorate degree in 2000, and doctorate degree in 2000 from Universidad de Buenos Aires.
Aktive Positionen von Gustavo Mahler
| Unternehmen | Position | Beginn |
|---|---|---|
Lucid Scientific, Inc.
 Lucid Scientific, Inc. Internet Software/ServicesTechnology Services Lucid Scientific, Inc. provides technology services. The company is headquartered in Atlanta, GA. | Direktor/Vorstandsmitglied | - |
Alpenglow Biosciences, Inc.
 Alpenglow Biosciences, Inc. Medical SpecialtiesHealth Technology Alpenglow Biosciences, Inc. engages in the development and production of three-dimensional open-top light-sheet microscope for the improvement of conducting pathology. The company was founded by Steven Buckley, Adam Glaser, Jonathan Liu, Nicholas Reder, and Larry True in 2018 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
CellFE, Inc.
 CellFE, Inc. BiotechnologyHealth Technology CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA. | Direktor/Vorstandsmitglied | - |
Curi Bio, Inc.
 Curi Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
Vernal Biosciences, Inc.
 Vernal Biosciences, Inc. BiotechnologyHealth Technology Vernal Biosciences, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that specializes in manufacturing and formulating mRNA and LNP-mRNA. Vernal's focus is on democratizing access to their expertise and unparalleled LNP-platform technologies to accelerate the potential of mRNA. The American company provides comprehensive high purity platform manufacturing solutions for mRNA-based medicines, from research to clinical development. Vernal Biosciences is pioneering the custom development and manufacturing process for a variety of applications including vaccine development, gene replacement, and more. The company was founded in 2021 and is headquartered just outside of an undisclosed location. The company was founded by Cobaugh Christian, who has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Vorstandsvorsitzender | 05.01.2023 |
Cellistic
 Cellistic BiotechnologyHealth Technology Part of Ncardia SA, Cellistic is a subsidiary that specializes in the process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The Belgian company's focus and expertise in iPSC reprogramming, differentiation, and expansion protocol development make it an ideal partner for innovative cell therapy developers to commercialize novel advanced therapies. The company was founded by Stefan Braam, and Gustavo Mahler has been the CEO of the company since 2023. | Vorstandsvorsitzender | 05.01.2023 |
Ehemalige bekannte Positionen von Gustavo Mahler
| Unternehmen | Position | Ende |
|---|---|---|
Dynamk Capital LLC
 Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York. | Private Equity Investor | 31.12.2022 |
| Life Science Washington | Direktor/Vorstandsmitglied | 31.12.2022 |
| ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Gustavo Mahler
| Universidad de Buenos Aires | Doctorate Degree |
| Universidad Nacional de Educación a Distancia | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BAYER AG | Health Technology |
| ABSCI CORPORATION | Health Technology |
| Private Unternehmen | 12 |
|---|---|
AGC Biologics A/S
 AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Health Technology |
AGC Biologics, Inc.
 AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology AGC Biologics, Inc. develops therapeutic proteins for early clinical trials. The firm offers integrated cGMP manufacturing services using microbial fermentation and mammalian cell culture processes. The company was founded in 2007 and is headquartered in Bothell, WA. | Health Technology |
Dynamk Capital LLC
Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York. | Finance |
Lucid Scientific, Inc.
Lucid Scientific, Inc. Internet Software/ServicesTechnology Services Lucid Scientific, Inc. provides technology services. The company is headquartered in Atlanta, GA. | Technology Services |
Alpenglow Biosciences, Inc.
Alpenglow Biosciences, Inc. Medical SpecialtiesHealth Technology Alpenglow Biosciences, Inc. engages in the development and production of three-dimensional open-top light-sheet microscope for the improvement of conducting pathology. The company was founded by Steven Buckley, Adam Glaser, Jonathan Liu, Nicholas Reder, and Larry True in 2018 and is headquartered in Seattle, WA. | Health Technology |
| Life Science Washington | |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Health Services |
CellFE, Inc.
CellFE, Inc. BiotechnologyHealth Technology CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA. | Health Technology |
Curi Bio, Inc.
Curi Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA. | Commercial Services |
Vernal Biosciences, Inc.
Vernal Biosciences, Inc. BiotechnologyHealth Technology Vernal Biosciences, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that specializes in manufacturing and formulating mRNA and LNP-mRNA. Vernal's focus is on democratizing access to their expertise and unparalleled LNP-platform technologies to accelerate the potential of mRNA. The American company provides comprehensive high purity platform manufacturing solutions for mRNA-based medicines, from research to clinical development. Vernal Biosciences is pioneering the custom development and manufacturing process for a variety of applications including vaccine development, gene replacement, and more. The company was founded in 2021 and is headquartered just outside of an undisclosed location. The company was founded by Cobaugh Christian, who has been the CEO since incorporation. | Health Technology |
Ncardia SA
Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Commercial Services |
Cellistic
Cellistic BiotechnologyHealth Technology Part of Ncardia SA, Cellistic is a subsidiary that specializes in the process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The Belgian company's focus and expertise in iPSC reprogramming, differentiation, and expansion protocol development make it an ideal partner for innovative cell therapy developers to commercialize novel advanced therapies. The company was founded by Stefan Braam, and Gustavo Mahler has been the CEO of the company since 2023. | Health Technology |
